ZBH · 8-K · 20260805PR335108
Revenue Performance and Mix
ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 43 · Surprise 32 · No source text
2025 net sales increased 7.2% to $8,231.5 million from $7,678.6 million in 2024, with Paragon 28 contributing 2.5 percentage points and foreign exchange contributing 0.8 percentage points to growth. U.S. sales rose 7.3% to $4,764.0 million, while International sales increased 7.0% to $3,467.5 million. S.E.T. sales increased 15.2% to $2,150.2 million, including a 10.5 percentage-point contribution from Paragon 28, while Knees and Hips each increased 4.7%. Volume and mix contributed 6.4% to year-over-year sales growth, while global selling prices had a minimal effect.
Key facts
- Paragon 28 is estimated to contribute an additional 1.0 percent to year-over-year net sales growth until it eclipses the one year anniversary of deal closing in April 2026. source
- Net sales by geography: United States $4,764.0 million, International $3,467.5 million, Total $8,231.5 million for year ended December 31, 2025. source
- Net sales by product category for 2025: Knees $3,322.3 million, Hips $2,093.5 million, S.E.T. $2,150.2 million, Technology & Data, Bone Cement and Surgical $665.6 million, Total $8,231.5 million. source
- Net sales in 2025: United States $4,764.0 million; International $3,467.5 million; Total $8,231.5 million. source
- Net sales by product category in 2025: Knees $3,322.3 million; Hips $2,093.5 million; S.E.T $2,150.2 million; Technology & Data, Bone Cement and Surgical $665.6 million; Total $8,231.5 million. source
- Segment Net Sales 2025: Americas $5,191.1 million; EMEA $1,799.2 million; Asia Pacific $1,241.2 million; Total $8,231.5 million. source
- Segment profit 2025: Americas $2,188.4 million; EMEA $583.9 million; Asia Pacific $433.8 million; Total segment profit $3,206.1 million. source
- Net sales increased 7.2 percent in 2025 when compared to 2024. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +1.0% | Paragon 28 is estimated to contribute an additional 1.0 percent to year-over-year net sales growth until it eclipses the one year… |
| revenue | positive | realized | — | Segment Net Sales 2025: Americas $5,191.1 million; EMEA $1,799.2 million; Asia Pacific $1,241.2 million; Total $8,231.5 million. |
| revenue | positive | realized | — | Segment Net Sales 2025: Americas $5,191.1 million; EMEA $1,799.2 million; Asia Pacific $1,241.2 million; Total $8,231.5 million. |
| revenue | positive | realized | — | Segment Net Sales 2025: Americas $5,191.1 million; EMEA $1,799.2 million; Asia Pacific $1,241.2 million; Total $8,231.5 million. |
| operating_income | positive | realized | — | Segment profit 2025: Americas $2,188.4 million; EMEA $583.9 million; Asia Pacific $433.8 million; Total segment profit $3,206.1 million. |
| operating_income | positive | realized | — | Segment profit 2025: Americas $2,188.4 million; EMEA $583.9 million; Asia Pacific $433.8 million; Total segment profit $3,206.1 million. |
| operating_income | positive | realized | — | Segment profit 2025: Americas $2,188.4 million; EMEA $583.9 million; Asia Pacific $433.8 million; Total segment profit $3,206.1 million. |